Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Avant Technologies ( (AVAI) ).
On November 1, 2025, Avant Technologies Inc. entered into a Joint Venture and License Agreement with SGAustria Pte. Ltd. to form Insulinova, Inc., a new venture aimed at leveraging Austrianova’s proprietary cell encapsulation technology. Avant Technologies will provide up to $1.5 million USD in capital and resources for Insulinova’s operations over the next 18 months, with both companies holding equal ownership. This partnership is expected to enhance Avant’s industry positioning by integrating advanced biotech capabilities.
More about Avant Technologies
Avant Technologies Inc. operates in the technology sector, focusing on innovative solutions and partnerships to enhance its market position.
Average Trading Volume: 109,856
Technical Sentiment Signal: Strong Sell
Current Market Cap: $53.34M
See more insights into AVAI stock on TipRanks’ Stock Analysis page.